Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CONTEXT: Benzodiazepine drugs are highly effective anxiolytic medications, but the role of the benzodiazepine-gamma-aminobutyric acid(A)-chloride ion channel macromolecular complex in the pathophysiologic mechanism of anxiety is not well understood. Previous human imaging studies have indicated involvement of specific regions of the brain in anxiety disorders, especially the frontal-prefrontal, temporal, and cingulate cortical and the limbic areas. OBJECTIVE: To identify potential abnormalities of brain benzodiazepine receptor binding number and distribution in anxiety disorders. SETTING AND PARTICIPANTS: At the University of Michigan positron emission tomography facility, 11 individuals with DSM-IV-defined anxiety syndrome panic disorder were compared with 21 unaffected healthy control subjects. Design and Main Outcome Measure In a between-group comparison, we used positron emission tomography and the benzodiazepine receptor ligand flumazenil labeled with carbon 11 to assess the regional brain pattern of receptor binding. RESULTS: We observed decreased binding specifically in the insular cortex bilaterally. No binding abnormality was observed in any other brain region, and there was no evidence of abnormal cerebral blood flow anywhere in the brain. Individuals with panic disorder and comorbid depression, indicative of a more severe disorder, had the lowest binding. No significant correlations were observed for binding with age, sex, or duration of disorder. CONCLUSIONS: A previous smaller study with the same ligand reported a probable binding abnormality in the right insula. Because gamma-aminobutyric acid is a major inhibitory neurotransmitter in the brain and because benzodiazepines facilitate this effect of gamma-aminobutyric acid, decreased benzodiazepine binding is consistent with localized brain activation (ie, loss of inhibition). Because the insula is strongly involved in visceral-somatic afferent and efferent function, activation of the insula is consistent with the occurrence of the physical symptoms prominently associated with panic disorder.

Original publication

DOI

10.1001/archpsyc.64.7.793

Type

Journal article

Journal

Archives of general psychiatry

Publication Date

07/2007

Volume

64

Pages

793 - 800

Addresses

Department of Psychiatry, University of Michigan Medical Center, c/o 1215 Southwood Ct, Ann Arbor, MI 48103-9735, USA. ocameron@umich.edu

Keywords

Brain, Cerebral Cortex, Humans, Carbon Radioisotopes, Flumazenil, Receptors, GABA-A, Positron-Emission Tomography, Panic Disorder, Depressive Disorder, Comorbidity, Binding Sites, Tissue Distribution, Regional Blood Flow, Adult, Middle Aged, Female, Male, Functional Laterality